NH Insurance Department Bulletin INS 24-011-AB
USE OF ARTIFICIAL INTELLIGENCE SYSTEMS BY INSURERS
The State of New Hampshire
Insurance Department
21 South Fruit Street, Suite 14
Concord, NH 03301
David J. Bettencourt
Commissioner
Keith E. Nyhan
Deputy Commissioner
Telephone 603-271-2261 • Fax 603-271-1406 • TDD Access: Relay NH 1-800-735-2964
nh.gov/insurance
BULLETIN
Docket #INS 24-011-AB
TO:
“All Insurers Licensed to Do Business In New Hampshire (“Insurers”)”
FROM:
Commissioner David J. Bettencourt
DATE:
February 20, 2024
RE:
USE OF ARTIFICIAL INTELLIGENCE SYSTEMS BY INSURERS
The Department issues this bulletin to remind insurers that Artificial Intelligence (AI)
Systems must comply with all applicable insurance laws and regulations. This bulletin
sets forth the Department’s expectations as to how Insurers will govern the
development/acquisition and use of certain AI technologies, including the AI Systems
described herein. This bulletin also advises Insurers of the type of information and
documentation that the Department may request during an investigation or
examination of any Insurer regarding its use of such technologies and AI Systems.
SECTION 1: INTRODUCTION, BACKGROUND, AND LEGISLATIVE
AUTHORITY
Background
The Department encourages the development and use of innovation and AI Systems
that contribute to safe and stable insurance markets. However, the Department
expects that decisions made and actions taken by Insurers using AI Systems will
comply with all applicable federal and state laws.
The Department recognizes the Principles of Artificial Intelligence that the NAIC
adopted in 2020 as an appropriate source of guidance for Insurers as they develop
and use AI systems. Those principles emphasize the importance of the fairness and
ethical use of AI; accountability; compliance with state laws and regulations;
transparency; and a safe, secure, fair, and robust system. These fundamental
principles should guide Insurers in their development and use of AI Systems and
underlie the expectations set forth in this bulletin.
2
Legislative Authority
The regulatory expectations and oversight considerations set forth in Section 3 and
Section 4 of this bulletin rely on the following laws and regulations:
•
Unfair Trade Practices Act, RSA 417: The Unfair Trade Practices Act (UTPA)
regulates trade practices in insurance by: 1) defining practices that constitute
unfair methods of competition or unfair or deceptive acts and practices; and
2) prohibiting the trade practices so defined or determined. The Unfair Claims
Settlement Practices (UCSP) provision of the UTPA set forth standards for the
investigation and disposition of claims arising under policies or certificates of
insurance issued to residents of New Hampshire.
Actions taken by Insurers in the state must not violate the UTPA regardless of the
methods the Insurer used to determine or support its actions. As discussed below,
Insurers are expected to adopt practices, including governance frameworks and risk
management protocols, that are designed to ensure that the use of AI Systems does
not result in unfair trade practices as defined in the UTPA.
•
Corporate Governance Annual Disclosure Act, RSA 401-D: The Corporate
Governance Annual Disclosure Act (CGAD), requires Insurers to report on
governance practices and to provide a summary of the Insurer’s corporate
governance structure, policies, and practices. The content, form, and filing
requirements for CGAD information are set forth in the Corporate Governance
Annual Disclosure Model Act.
The requirements of CGAD apply to elements of the Insurer’s corporate governance
framework that address the Insurer’s use of AI Systems to support actions and
decisions that impact consumers.
•
Property and Casualty Rate Standards Law RSA 412:15: The Property
and Casualty Rate Standards Law requires that property and Casualty
insurance rates not be excessive (non-competitive lines), inadequate, or
unfairly discriminatory.
The requirements of the rates standards law apply regardless of the methodology
that the Insurer used to develop rates, rating rules, and rating plans subject to those
provisions. That means that an Insurer is responsible for assuring rates, rating rules,
and rating plans that are developed using AI techniques and Predictive Models that
rely on data and Machine Learning do not result in excessive, inadequate, or unfairly
discriminatory insurance rates. with respect to all forms of casualty insurance—
including fidelity, surety, and guaranty bond—and to all forms of property insurance—
including fire, marine, and inland marine insurance, and any combination of any of
the foregoing.
3
An Insurer’s conduct in the state, including its use of AI Systems to make or support
actions and decisions that impact consumers, is subject to investigation and
examination, including market conduct actions under RSA 400-A:16 (Investigations)
and 400-A:37 (Examinations). Section 4 of this bulletin provides guidance on the
kinds of information and documents that the Department may request in the context
of an AI-focused investigation or examination.
SECTION 2: DEFINITIONS
For the purposes of this bulletin, the following terms are defined:
“Adverse Consumer Outcome” refers to a decision by an Insurer, which is subject
to insurance laws and regulatory standards enforced by the Department, that
adversely impacts the consumer in a manner that violates those laws.
“Algorithm” means a clearly specified mathematical process for computation; a set
of rules that, if followed, will give a prescribed result.
“AI Systems” are machine-based systems that can, for a given set of objectives,
generate outputs such as predictions, recommendations, content (such as text,
images, videos, or sounds), or other output influencing decisions made in real or
virtual environments. AI Systems are designed to operate with varying levels of
autonomy.
“Artificial Intelligence (AI)” refers to a branch of computer science that uses data
processing systems that perform functions normally associated with human
intelligence, such as reasoning, learning, and self-improvement, or the capability of
a device to perform functions that are normally associated with human intelligence
such as reasoning, learning, and self-improvement. This definition considers Machine
Learning to be a subset of Artificial Intelligence.
“Degree of Potential Harm to Consumers” refers to the severity of adverse
economic impact that a consumer might experience as a result of an Adverse
Consumer Outcome.
“Generative Artificial Intelligence (Generative AI)” refers to a class of AI
Systems that generate content in the form of data, text, images, sounds, or video,
that is similar to, but not a direct copy of, pre-existing data or content.
“Machine Learning (ML)” Refers to a field within Artificial Intelligence that focuses
on the ability of computers to learn from provided data without being explicitly
programmed.
“Model Drift” refers to the decay of a model’s performance over time arising from
underlying changes such as the definitions, distributions, and/or statistical properties
between the data used to train the model and the data on which it is deployed.
4
“Predictive Model” refers to the mining of historic data using Algorithms and/or
Machine Learning to identify patterns and predict outcomes that can be used to make
or support the making of decisions.
“Third Party” for purposes of this bulletin means an organization other than the
Insurer that provides services, data, or other resources related to AI.
SECTION 3: REGULATORY GUIDANCE AND EXPECTATIONS
Decisions subject to regulatory oversight that are made by Insurers using AI Systems
must comply with the statutes and regulatory standards that apply to those decisions.
These laws require, at a minimum, that decisions made by Insurers are not
inaccurate, arbitrary, capricious, or unfairly discriminatory. Compliance with these
laws is required regardless of the tools and methods Insurers use to make such
decisions. In the absence of proper controls, AI has the potential to increase the risk
of inaccurate, arbitrary, capricious, or unfairly discriminatory outcomes for
consumers. As such, it is important that Insurers adopt and implement controls
specifically related to their use of AI that are designed to mitigate the risk of Adverse
Consumer Outcomes.
All Insurers authorized to do business in New Hampshire are expected to develop,
implement, and maintain a written program (an “AIS Program”) for the responsible
use of AI Systems that make, or support decisions related to regulated insurance
practices. The AIS Program should be designed to mitigate the risk of Adverse
Consumer Outcomes, including, at a minimum, the statutory provisions set forth in
Section 1 of this bulletin.
The Department recognizes that robust governance, risk management controls, and
internal audit functions play a core role in mitigating the risk that decisions driven by
AI Systems will violate unfair trade practice laws and regulatory standards. The
Department strongly encourages the development and use of verification and testing
methods to identify errors in Predictive Models and AI Systems to limit the potential
for unfair discrimination in the decisions and outcomes resulting from the use of
Predictive Models and AI Systems.
The controls and processes that an Insurer adopts and implements as part of its AIS
Program should be reflective of, and commensurate with, the degree and nature of
risk posed to consumers by the AI Systems that it uses, considering: (i) the nature
of the decisions being made, informed, or supported using the AI System; (ii) the
type and Degree of Potential Harm to Consumers resulting from the use of AI
Systems; (iii) the extent to which humans are involved in the final decision-making
process; (iv) the transparency and articulable outcomes to the impacted consumer;
and (v) the extent and scope of the insurer’s use or reliance on data, Predictive
Models, and AI Systems from Third Parties. Similarly, controls and processes should
be commensurate with both the risk of Adverse Consumer Outcomes and the Degree
of Potential Harm to Consumers.
5
As discussed in Section 4, the decisions made as a result of an Insurer’s use of AI
Systems are subject to the Department’s examination to determine that the reliance
on AI Systems are compliant with all applicable statutes and regulatory standards
governing the conduct of the Insurer.
AIS Program Guidelines
To help ensure compliance with the above-mentioned statutory requirements (RSA
417, RSA 412:15, & RSA 400-A:16 &37), insurers should consider the following
guidelines.
1.0
General Guidelines
1.1
The AIS Program should be designed to mitigate the risk that the
Insurer’s use of an AI System will result in Adverse Consumer Outcomes.
1.2
The AIS Program should address governance, risk management
controls, and internal audit functions.
1.3
The AIS Program should vest responsibility for the development,
implementation, monitoring, and oversight of the AIS Program and for setting the
Insurer’s strategy for AI Systems with senior management.
1.4
The AIS Program should be tailored to and proportionate with the
Insurer’s use and reliance on AI and AI Systems. Controls and procedures should be
focused on the mitigation of Adverse Consumer Outcomes and the scope of the
controls and procedures applicable to a given AI System use case should reflect and
align with the Degree of Potential Harm to Consumers with respect to that use case.
1.5
The AIS Program may be independent of or part of the Insurer’s existing
Enterprise Risk Management (ERM) program. The AIS Program may adopt,
incorporate, or rely upon, in whole or in part, a framework or standards developed
by an official Third-Party standard organization, such as the National Institute of
Standards and Technology (NIST) Artificial Intelligence Risk Management
Framework, Version 1.0.
1.6
The AIS Program should address the use of AI Systems across the
insurance life cycle, including areas such as product development and design,
marketing, use, underwriting, rating and pricing, case management, claim
administration and payment, and fraud detection.
1.7
The AIS Program should address all phases of an AI System’s life cycle,
including design, development, validation, implementation (both systems and
business), use, on-going monitoring, updating and retirement.
1.8
The AIS Program should address the AI Systems used with respect to
regulated insurance practices whether developed by the Insurer or a Third-Party
vendor.
6
1.9
The AIS Program should include processes and procedures providing
notice to impacted consumers that AI Systems are in use and provide access to
appropriate levels of information based on the phase of the insurance life cycle in
which the AI Systems are being used.
2.0
Governance
The AIS Program should include a governance framework for the oversight of AI
Systems used by the Insurer. Governance should prioritize transparency, fairness,
and accountability in the design and implementation of the AI Systems, recognizing
that proprietary and trade secret information must be protected. An Insurer may
consider adopting new internal governance structures or rely on the Insurer’s existing
governance structures; however, in developing its governance framework, the
Insurer should consider addressing the following items:
2.1
The policies, processes, and procedures, including risk management and
internal controls, to be followed at each stage of an AI System life cycle, from
proposed development to retirement.
2.2
The requirements adopted by the Insurer to document compliance with
the AIS Program policies, processes, procedures, and standards. Documentation
requirements should be developed with Section 4 in mind.
2.3
The Insurer’s internal AI System governance accountability structure,
such as:
a) The formation of committees comprised of representatives from
appropriate disciplines and units within the Insurer, such as business
units, product specialists, actuarial, data science and analytics,
underwriting, claims, compliance, and legal.
b) Scope of responsibility and authority, chains of command, and
decisional hierarchies.
c) The independence of decision-makers and lines of defense at
successive stages of the AI System life cycle.
d) Monitoring, auditing, escalation, and reporting protocols and
requirements.
e) Development
and
implementation
of
ongoing
training
and
supervision of personnel.
2.4
Specifically with respect to Predictive Models: the Insurer’s processes
and procedures for designing, developing, verifying, deploying, using, updating, and
7
monitoring Predictive Models, including a description of methods used to detect and
address errors, performance issues, outliers, or unfair discrimination in the insurance
practices resulting from the use of the Predictive Model.
3.0
Risk Management and Internal Controls
The AIS Program should document the Insurer’s risk identification, mitigation, and
management framework and internal controls for AI Systems generally and at each
stage of the AI System life cycle. Risk management and internal controls should
address the following items:
3.1
The oversight and approval process for the development, adoption, or
acquisition of AI Systems with constraints and controls on automation and design to
mitigate risks that would be inconsistent with the above-mentioned statutes.
3.2
Data practices and accountability procedures, including data currency,
lineage, quality, integrity, unfair bias analysis and minimization, and suitability.
3.3
Management and oversight of Predictive Models (including Algorithms
used therein), including:
a) Inventories and descriptions of the Predictive Models.
b) Detailed documentation of the development and use of the
Predictive Models.
c) Assessments such as interpretability, repeatability, robustness,
regular tuning, reproducibility, traceability, Model Drift, and the
auditability of these measurements where appropriate.
3.4
Validating, testing, and retesting as necessary to assess the
generalization of AI System outputs upon implementation, including the suitability of
the data used to develop, train, validate and audit the model. Validation can take the
form of comparing model performance on unseen data available at the time of model
development to the performance observed on data post-implementation, measuring
performance against expert review, or other methods.
3.5
The protection of non-public information, particularly consumer
information, including unauthorized access to the Predictive Models themselves.
3.6
Data and record retention.
3.7
Specifically with respect to Predictive Models: a narrative description of
the model’s intended goals and objectives and how the model is developed and
validated to ensure that the AI Systems that rely on such models correctly and
efficiently predict or implement those goals and objectives.
4.0
Third-Party AI Systems and Data
8
Each AIS Program should address the Insurer’s process for acquiring, using, or relying
on (i) Third-Party data to develop AI Systems; and (ii) AI Systems developed by a
Third Party, which may include, the establishment of standards, policies, procedures,
and protocols relating to the following considerations:
4.1
Due diligence and the methods employed by the Insurer to assess the
Third Party and its data or AI Systems acquired from the Third Party to ensure that
decisions made or supported from such AI Systems that could lead to Adverse
Consumer Outcomes will comply with statutes and regulatory standards.
4.2
Where appropriate and available, the inclusion of terms in contracts with
Third Parties that:
a)
Provide audit rights and/or entitle the Insurer to receive audit reports
by qualified auditing entities.
b)
Require the Third Party to cooperate with the Insurer regarding
regulatory inquiries and investigations related to the Insurer’s use of the
Third Party’s product or services.
4.3
The performance of contractual rights regarding audits and/or other
activities to confirm the Third Party’s compliance with contractual and regulatory
requirements.
SECTION 4: REGULATORY OVERSIGHT AND EXAMINATION
CONSIDERATIONS
The Department’s regulatory oversight of Insurers includes oversight of an Insurer’s
conduct in the state, including its use of AI Systems to make or support decisions
that impact consumers. Regardless of the existence or scope of a written AIS
Program, in the context of a Department action, an Insurer can expect to be asked
about its development, deployment, and use of AI Systems, or any specific Predictive
Model, AI System or application and its outcomes (including Adverse Consumer
Outcomes) from the use of those AI Systems, as well as any other information or
documentation deemed relevant by the Department.
Insurers should expect those inquiries to include, but not be limited to, the Insurer’s
governance framework, risk management, and internal controls (including the
considerations identified in Section 3). In addition to conducting a review of any of
the items listed in this Bulletin, a regulator may also ask questions regarding any
specific model, AI System, or its application, including requests for the following types
of information and/or documentation:
9
1.0
Information and Documentation Relating to AI System Governance,
Risk Management, and Use Protocols
1.1.
Information and documentation related to the Insurer’s AIS Program,
including:
a) The written AIS Program.
b) Information and documentation relating to the adoption of the AIS
Program.
c) The scope of the Insurer’s AIS Program, including any AI Systems
and technologies not included in or addressed by the AIS Program.
d) How the AIS Program is tailored to and proportionate with the
Insurer’s use and reliance on AI Systems, the risk of Adverse
Consumer Outcomes, and the Degree of Potential Harm to
Consumers.
e) The policies, procedures, guidance, training materials, and other
information relating to the adoption, implementation, maintenance,
monitoring, and oversight of the Insurer’s AIS Program, including:
i.
Processes and procedures for the development, adoption, or
acquisition of AI Systems, such as:
(1) Identification of constraints and controls on automation and
design.
(2) Data governance and controls, any practices related to data
lineage,
quality,
integrity,
unfair
bias
analysis
and
minimization, suitability, and data currency.
ii. Processes and procedures related to the management and
oversight of Predictive Models, including measurements, statutes
and regulatory standards, or thresholds adopted or used by the
Insurer in the development, validation, and oversight of models
and AI Systems.
iii. Protection of non-public information, particularly consumer
information, including unauthorized access to Predictive Models
themselves.
1.2.
Information and documentation relating to the Insurer’s preacquisition/pre-use diligence, monitoring, oversight, and auditing of data or AI
Systems developed by a Third Party.
10
1.3.
Information and documentation relating to the Insurer’s implementation
and compliance with its AIS Program, including documents relating to the Insurer’s
monitoring and auditing activities respecting compliance, such as:
a) Documentation relating to the formation and ongoing operation of
the Insurer’s coordinating bodies for the development, use, and
oversight of AI Systems.
b) Documentation related to data practices and accountability
procedures, including data lineage, quality, integrity, unfair bias
analysis and minimization, suitability, and data currency.
c) Management and oversight of Predictive Models and AI Systems,
including:
i.
The Insurer’s inventories and descriptions of Predictive Models,
and AI Systems used by the Insurer to make or support decisions
that can result in Adverse Consumer Outcomes.
ii.
As to any specific Predictive Model or AI System:
(1) Documentation of compliance with all applicable AI Program
policies, protocols, and procedures in the development, use,
and oversight of Predictive Models and AI Systems deployed
by the Insurer.
(2) Information about data used in the development and oversight
of the specific model or AI System, including the data source,
provenance, data lineage, quality, integrity, unfair bias
analysis and minimization, suitability, and data currency.
(3) Information related to the techniques, measurements,
thresholds, and similar controls used by the Insurer.
d) Documentation related to validation, testing, and auditing, including
evaluation of drift to assess the reliability of outputs that influence
the decisions made based on Predictive Models. Note that the nature
of validation, testing, and auditing should be reflective of the
underlying components of the AI System, whether based on
Predictive Models or Generative AI.
2.
Third-Party AI Systems and Data
In addition, if the investigation or examination concerns data, Predictive Models, or
AI Systems collected or developed in whole or in part by Third Parties, the Insurer
should also expect the Department to request the following additional types of
information and documentation.
11
2.1
Due diligence conducted on Third Parties and their data, models, or AI
Systems.
2.2
Contracts with Third-Party AI System, model, or data vendors, including
terms relating to representations, warranties, data security and privacy,
data
sourcing,
intellectual
property
rights,
confidentiality
and
disclosures, and/or cooperation with regulators.
2.3
Audits and/or confirmation processes performed regarding Third-Party
compliance with contractual and, where applicable, regulatory
obligations.
2.4
Documentation pertaining to validation, testing, and auditing, including
evaluation of Model Drift.
The Department recognizes that Insurers may demonstrate their compliance with
New Hampshire laws that regulate their conduct in their use of AI Systems through
alternative means, including through practices that differ from those described in this
bulletin. The goal of the bulletin is not to mandate specific practices or documentation
requirements. Rather, the goal is to ensure that Insurers in the state are aware of
the Department’s expectations as to how AI Systems are governed and managed and
of the kinds of information and documents about an Insurer’s AI Systems that the
department expects an Insurer to produce when requested.
As in all cases, investigations and market conduct actions may be performed using
procedures that vary in nature, extent, and timing in accordance with regulatory
judgment. Work performed may include inquiry, examination of company
documentation, or any of the continuum of market actions described in the NAIC’s
Market Regulation Handbook. These activities may involve the use of contracted
specialists with relevant subject matter expertise. Nothing in this bulletin limits the
authority of the Department to conduct any regulatory investigation, examination,
or enforcement action relative to any act or omission of any Insurer that the
Department is authorized to perform.
If you have any questions about this bulletin, please contact Christian Citarella,
Chief Property & Casualty Actuary, at christian.g.citarella@ins.nh.gov.